Enabling use of blood spot cards for accurate high-throughput Fragile X screening
ASURAGEN, INC. · Department of Health and Human Services
Phase I2011$346,302
DESCRIPTION (provided by applicant): The long-term goal of this project is to develop accurate, rapid, high-throughput and cost-effective diagnostic tests for Fragile X syndrome (FXS) and related disorders in anticipati…